leadf
logo-loader
NASDAQ:CLXT

Calyxt

Receive alerts
Market:
NASDAQ
Market Cap:
$203.09 m
Price
6.12 USD
Change
-1.77%
52 weeks high
8.39
52 weeks low
2.42

Calyxt (NASDAQ: CLXT) is a plant-based innovation company that utilizes our patented breeding technology to make the food you love a healthier choice. The care we take extends beyond nutritional value. We partner with farmers and food companies to deliver traceable plant-based products developed to be healthier and more sustainable than their conventional counterparts. We use cutting edge plant breeding techniques to develop products that help improve diets by reducing bad fats, allergens and toxins. We continuously pursue innovation to deliver good food that is good for you.

US

Jim Blome

Chief Executive Officer

Jim grew up on a family corn and soybean farm in Hubbard, Iowa, and is a graduate of Iowa State University. Prior to joining Calyxt, Jim was the President and CEO for Bayer CropScience LP (North America). He also held executive positions at Valent (Sumitomo Chemical), Agtrol International and Agriliance LLC (a Land O’ Lakes and CHS joint venture). Jim currently serves as the Independent Non-Executive Chairman of Concentric Ag Technologies; Inc. He is the 2013 recipient of the Henry A. Wallace Award from Iowa State University for outstanding leadership and service to agriculture.

Dan Voytas

Chief Science Officer

Dan graduated summa cum laude from Harvard College in 1984 and received his Ph.D. in genetics from Harvard Medical School in 1990. He is a co-founder of Calyxt and one of the inventors of the TALEN® technology. In addition to his role at Calyxt, Voytas is a professor in the Department of Genetics, Cell Biology and Development at the University of Minnesota (UMN), which he joined in 2008, and is Director of the UMN’s Center for Precision Plant Genomics. In 1992, Voytas joined the faculty at Iowa State University. Prior to this, he conducted postdoctoral research at Johns Hopkins University School of Medicine. Dan is an elected Fellow of the American Association for the Advancement of Science and the National Academy of Sciences.

Bill Koschak

Chief Financial Officer

Bill brings over brings over 10 years of corporate, finance and accounting leadership to Calyxt as an operating or corporate CFO. Prior to joining Calyxt, Bill was Vice President, Finance for the Brain Therapies business unit of Medtronic (NYSE: MDT). He has held executive positions at Young America Holdings, General Mills (NYSE:GIS), and KPMG LLP. Bill was recognized as a CFO of the Year by the Twin Cities Business Journal in 2016 and currently serves on the board of 1st Financial Bank USA and Second Harvest Heartland.

Debra Frimerman

General Counsel and Corporate Secretary

Debra brings agriculture and food industry legal expertise to Calyxt. Previously, Debra was Associate General Counsel for Syngenta North America and acting general counsel for Syngenta Seeds, LLC. Through her seven years at Syngenta, Debra provided counsel for executive leadership teams and contributed to the closing of numerous global transactions; launching new products into new markets; and developing regulatory, compliance and corporate policies. Prior to her role at Syngenta, Debra practiced law at Stoel Rives LLP and Lindquist & Vennum PLLP.

Travis Frey

Chief Technology Officer

Travis brings over 15 years of experience in the agricultural industry and technology innovation to Calyxt. Travis received his B.S. in Horticulture from Penn State University, M.S. in Plant Breeding and Plant Genetics from the University of Wisconsin, Ph.D. in the Plant Biology and Biotechnology Program at the Univesity of Delaware and DuPont/Pioneer and an M.B.A from the University of Chicago – Booth School of Business. Prior to joining Calyxt, Travis held science and innovation leadership roles at WISErg Corporation and Monsanto.

Bobby Williams, Ph.D.

Director of Gene Editing

Dr. Williams has been on the forefront of advancements in plant sciences, and is an expert in the gene editing field. His accomplishments include developing new gene silencing technology and leading efforts to discover small RNAs to precisely engineer beneficial crop traits. In addition, Dr. Williams led gene discovery initiatives to improve crop traits to support sustainability, specifically drought resistance, improved nitrogen efficiency and yield enhancement.

With more than 15 years of expertise in the agriculture and seed industry, Dr. Williams most recently served as Senior Research Manager at Corteva Agriscience, where he led multiple trait discovery efforts and cross functional teams through field advancements. Prior to Corteva, Dr. Williams was a Helen Hay Whitney post-doctoral fellow at UC Berkeley studying Drosophila development under Gerald Rubin, Ph.D. He earned his Ph.D. in Biology at the California Institute of Technology in Pasadena, CA where he focused on plant developmental genetics with Elliot Meyerowitz, Ph.D.

Investor Relations

MZ Group
Chris Tyson
Managing Director
T: 949-491-8235
CLXT@mzgroup.us

Company

Calyxt, Inc.
2800 Mount Ridge Road
Roseville, MN 55113